Epidemiology and classification of bone tumors.

Primary bone tumors are uncommon and this has certainly contributed to the scarcity of data about their relative frequency, and to the limited understanding of the risk factors. Overall, bone sarcomas account for 0.2% of all malignancies, and the adjusted incidence rate for all bone and joint malignancies is 0.9 per 100,000 persons per year, while the 5-year overall survival rate is 67.9%. The age specific incidence rates of bone sarcomas show a bimodal distribution, with a first peak occurring in the second decade, and a second peak occurring in patients older than sixty, in relation with the age distribution of the main histological subtypes. Several bone tumor types occur in the setting of inherited syndromes, while some other develop in association with non-neoplastic precursors or in the setting of previous benign tumors. In recent years, significant advances have occurred in the molecular and cytogenetic characterization of benign and malignant bone tumors. The detection of clonal chromosomal aberrations, specific molecular genetic changes, and the identification of growth related tumor cell signaling pathways have resulted in a better understanding of the pathogenesis of several neoplastic entities, and have provided the basis for an improvement in the diagnostic workup and differential diagnosis of several bone tumors presenting with overlapping clinical, radiological and pathological features, as well as for the identification of new prognostic factors and therapeutic targets.

[1]  F. Mertens,et al.  Recurrent t(16;17)(q22;p13) in aneurysmal bone cysts. , 1999, Genes, chromosomes & cancer.

[2]  C. Antonescu,et al.  Primary Fibrosarcoma and Malignant Fibrous Histiocytoma of Bone - A Comparative Ultrastructural Study: Evidence of a Spectrum of Fibroblastic Differentiation , 2000, Ultrastructural pathology.

[3]  P. D. Dal Cin,et al.  Variant translocations involving 16q22 and 17p13 in solid variant and extraosseous forms of aneurysmal bone cyst , 2000, Genes, chromosomes & cancer.

[4]  F. Sim,et al.  Primary mixed tumor of bone , 2001, Skeletal Radiology.

[5]  F. Mertens,et al.  World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone , 2002 .

[6]  J. Vandenbroucke,et al.  Multiple primary malignancies in osteosarcoma patients. Incidence and predictive value of osteosarcoma subtype for cancer syndromes related with osteosarcoma , 2003, European Journal of Human Genetics.

[7]  P. Hogendoorn,et al.  Multiple Osteochondromas: Clinicopathological and Genetic Spectrum and Suggestions for Clinical Management , 2004, Hereditary cancer in clinical practice.

[8]  Y. Ueda,et al.  Benign Notochordal Cell Tumors: A Comparative Histological Study of Benign Notochordal Cell Tumors, Classic Chordomas, and Notochordal Vestiges of Fetal Intervertebral Discs , 2004, The American journal of surgical pathology.

[9]  E. Montgomery,et al.  Most Osteomalacia-associated Mesenchymal Tumors Are a Single Histopathologic Entity: An Analysis of 32 Cases and a Comprehensive Review of the Literature , 2004, The American journal of surgical pathology.

[10]  J. Fletcher,et al.  USP6 (Tre2) Fusion Oncogenes in Aneurysmal Bone Cyst , 2004, Cancer Research.

[11]  Ming Zhou,et al.  Cytogenetic and molecular cytogenetic findings in 43 aneurysmal bone cysts: aberrations of 17p mapped to 17p13.2 by fluorescence in situ hybridization , 2004, Modern Pathology.

[12]  F. Bertoni,et al.  Primary malignant myoepithelioma of the distal femur , 2007, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[13]  E. Montgomery,et al.  RT-PCR Analysis for FGF23 Using Paraffin Sections in the Diagnosis of Phosphaturic Mesenchymal Tumors With and Without Known Tumor Induced Osteomalacia , 2009, The American journal of surgical pathology.

[14]  M. Chou,et al.  TRE17/Ubiquitin-specific Protease 6 (USP6) Oncogene Translocated in Aneurysmal Bone Cyst Blocks Osteoblastic Maturation via an Autocrine Mechanism Involving Bone Morphogenetic Protein Dysregulation* , 2010, The Journal of Biological Chemistry.

[15]  C. Antonescu,et al.  EWSR1‐POU5F1 fusion in soft tissue myoepithelial tumors. A molecular analysis of sixty‐six cases, including soft tissue, bone, and visceral lesions, showing common involvement of the EWSR1 gene , 2010, Genes, chromosomes & cancer.

[16]  C. Fletcher,et al.  A Reappraisal of Hemangiopericytoma of Bone; Analysis of Cases Reclassified as Synovial Sarcoma and Solitary Fibrous Tumor of Bone , 2010, The American journal of surgical pathology.

[17]  J. Bovée,et al.  Primary vascular tumors of bone: a spectrum of entities? , 2011, International journal of clinical and experimental pathology.

[18]  M. Kyriakos Benign notochordal lesions of the axial skeleton: a review and current appraisal , 2011, Skeletal Radiology.